COVID-19 pill Paxlovid moves closer to full FDA approval
Headline from KOB 4, on the newest of 2 developments
U.S. health advisers are backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness. The panel of Food and Drug Administration experts agreed Thursday that the drug is safe and effective for preventing severe COVID-19…
KOB 4's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
COVID-19 pill Paxlovid moves closer to full FDA approval
Headline from WFMZ Allentown ·
Newest
COVID-19 pill Paxlovid moves closer to full FDA approval
FDA staff said Pfizer’s clinical trial results on its Covid antiviral pill Paxlovid support its use in adults at high risk of progressing to severe disease.
A U.S. Food and Drug Administration advisory panel will discuss whether to recommend Pfizer's COVID-19 treatment Paxlovid for full approval during a meeting Thursday.
U.S. health advisers are backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness. The panel of Food and Drug Administration experts agreed Thursday that the drug is safe and effective for preventing severe COVID-19…
As the US Food and Drug Administration's independent advisers prepare to discuss Thursday the full approval of Pfizer's COVID-19 antiviral, Paxlovid, agency experts said this week that clinical trial data shows that it is safe and effective for treatment of mild to moderate illness in high-risk adul…
FRIDAY, March 17, 2023 (HealthDay News) -- Paxlovid, a medication that has helped millions of high-risk COVID patients avoid hospitalization and death since late 2021, moved one step closer to
Advisers to the U.S. Food and Drug Administration voted 16-1 on Thursday in support of full approval of Paxlovid, stating that the benefits outweigh the risks of the drug for
U.S. health regulators voted in favor of a full approval for Pfizer's COVID pill Paxlovid. This pill will will help adults who are at high risk of progression to severe virus.
FDA advisers voted in support of full approval of Paxlovid, stating that the benefits outweigh the risks of the drug for treatment of mild to moderate COVID-19.
Pfizer’s covid-19 pill Paxlovid won another vote of confidence from U.S. health advisers Thursday, clearing the way for its full regulatory approval by the Food and Drug Administration.
Identical headlines usually mean shared wire copy. They are counted as separate articles but are not independent confirmation.
